Atlas Trials

TYK Medicines, Inc

17 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch TYK Medicines, Inc

RecordFirmDate
Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors (NCT07282873)TYK Medicines, Inc2026-01-01
Study of TYK-00540 Combined With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC） (NCT07104643)TYK Medicines, Inc2025-08-01
Study of TY-302 Capsules Combined With Abiraterone in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC） (NCT07104617)TYK Medicines, Inc2025-08-01
A Study of TY-9591 With Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor NSCLC (NCT06672068)TYK Medicines, Inc2025-02-20
Studies Evaluating the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of TY-9591 Tablets in Healthy Subjects (NCT06255951)TYK Medicines, Inc2024-03-12
Study of TYK-00540 Tablets in Patients With Advanced Solid Tumors (NCT06950086)TYK Medicines, Inc2024-01-02
A Study of TYK-00540 in Adult Patients With Solid Tumors (NCT06246071)TYK Medicines, Inc2024-01-02
TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases (NCT05948813)TYK Medicines, Inc2023-08-17
A Study of TY-2699a in Patients With Locally Advanced or Metastatic Solid Tumors (NCT05866692)TYK Medicines, Inc2023-08-17
[14 C] Study on Mass Balance of TY-9591 in Healthy Chinese Subjects (NCT05871905)TYK Medicines, Inc2023-06-19
A Study of TY-1091 in Patients With Advanced Solid Tumors (NCT05675605)TYK Medicines, Inc2023-04-24
A Study of TY-2136b in Patients With Advanced Solid Tumors Harboring ALK, ROS1 or NTRK1-3 Alterations (NCT05769075)TYK Medicines, Inc2023-04-20
Phase III Study of TY-9591 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLETEO) (NCT05382728)TYK Medicines, Inc2022-06-08
Study of TY-9591 in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation (NCT05146219)TYK Medicines, Inc2022-04-02
A Study to Assess the Effect of Food on the Pharmacokinetics of TY-9591 in Healthy Volunteers (NCT04798638)TYK Medicines, Inc2021-04-30
A Study of TY-302 in Patients With Advanced Solid Tumors (NCT04433494)TYK Medicines, Inc2020-12-07
A Study of TY-9591 in Advanced Non-small Cell Lung Cancer(NSCLC) Patients With EGFR Positive Mutation (NCT04204473)TYK Medicines, Inc2020-05-07

Track TYK Medicines, Inc automatically

Every clearance here is in the API, with alerts when new ones post.